Work

Supplementary Figure 1 from Phase I Trial of Cyclophosphamide as an Immune Modulator for Optimizing Oncolytic Reovirus Delivery to Solid Tumors

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Figure 1. Total white blood cell numbers were reduced by higher doses of the cytotoxic CP in later cohorts

DOI: 10.1158/1078-0432.22458119.v1

Authors: Victoria Roulstone, Khurum Khan, Hardev S. Pandha, Sarah Rudman, Matt Coffey, George M. Gill, Alan A. Melcher, Richard Vile, Kevin J. Harrington, Johann de Bono, James Spicer

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361916571

Cites:

Cited by:

Related to: 10